Surgery Websites

Advancing Lobular Breast Cancer Research and Innovating Targeted Treatments to Improve the Lives of Patients

The Lobular Breast Cancer Research Program is the first research program in California dedicated to understanding invasive lobular carcinoma (ILC) and advancing lobular-specific research with the aim to pursue breakthroughs that improve patient lives and outcomes. Our research is supported by The Helen Diller Family Comprehensive Cancer Center and the American Cancer Society, as well as directly by patients and the wider community.

Recent Publications

Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.
Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.